Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ (ZX-ZP-0055)

• Status: Completed
• Trial end date: 2015-01-01

Summary

This is a randomized, paired-comparisons design where each subject receives two of the planned treatments.

• Phase: Phase 2

Details

• Lead Sponsor: Zurex Pharma, Inc.
• Treatments: Anti-Infective Agents; Chlorhexidine; Chlorhexidine gluconate; Ethanol